GLPG (Galapagos NV) Price-to-Tangible-Book : 0.73 (As of Jul. 15, 2025)

View and export this data going back to 2008. Start your Free Trial

What is Galapagos NV Price-to-Tangible-Book?

As of today (2025-07-15), Galapagos NV's share price is $30.27. Galapagos NV's Tangible Book per Share of Mar. 2025 for the quarter that ended in Mar. 2025 was $41.37. Hence, Galapagos NV's Price to Tangible Book Ratio of today is 0.73.

The historical rank and industry rank for Galapagos NV's Price-to-Tangible-Book or its related term are showing as below:

GLPG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.58 Med: 2.96 Max: 6.1
Current: 0.67

During the past 13 years, Galapagos NV's highest Price to Tangible Book Ratio was 6.10. The lowest was 0.58. And the median was 2.96.

GLPG's Price-to-Tangible-Book is ranked better than
91.49% of 1198 companies
in the Biotechnology industry
Industry Median: 3.045 vs GLPG: 0.67

A closely related ratio is called PB Ratio. As of today, Galapagos NV's share price is $30.27. Galapagos NV's Book Value per Sharefor the quarter that ended in Mar. 2025 was $45.08. Hence, Galapagos NV's P/B Ratio of today is 0.67.

Galapagos NV Price-to-Tangible-Book Historical Data

The historical data trend for Galapagos NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galapagos NV Price-to-Tangible-Book Chart

Galapagos NV Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.04

1.24

1.19

0.95

0.65

Galapagos NV Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.72	0.57	0.65	0.65	0.61

Competitive Comparison of Galapagos NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Galapagos NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Galapagos NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Galapagos NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Galapagos NV's Price-to-Tangible-Book falls into.

Save Embed

;

Save Embed

;

Galapagos NV Price-to-Tangible-Book Calculation

Galapagos NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Mar. 2025 )
	=	30.27	/	41.374
	=	0.73

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Galapagos NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Galapagos NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Galapagos NV Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Galapagos NV (NAS:GLPG) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

GLPGF:USA GLPG:Netherlands GLPGa:UK 0JXZ:UK GXEA:Germany GXE:Germany G1LP34:Brazil GLPG:Austria

Address

Generaal De Wittelaan L11 A3, Mechelen, BEL, 2800

Website

https://www.glpg.com

Galapagos NV is a fully integrated biotechnology company with operations in Europe and the United States, dedicated to developing medicines focusing on oncology and immunology. The group focuses on unmet medical needs, it synergizes compelling science, technology, and collaborative approaches to create a deep pipeline of medicines. Its clinical pipeline includes: GLPG5101, a CD19 CAR-T product candidate decentralized manufactured, currently in Phase 1/2 in rrNHL; GLPG5301, a BCMA CAR-T product candidate decentralized manufactured, currently in Phase 1 in rrMM; and GLPG3667, a TYK2 inhibitor currently in Phase 2 clinical trial in DM and SLE. It derives maximum revenue from the United States of America.